Alison Doody1, Sabrina Jackson1, Jessie A Elliott1, Ronan J Canavan2, C Godson1, David Slattery2, Patrick J Twomey3, Malachi J McKenna2, Carel W le Roux4, Neil G Docherty5. 1. Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College, Dublin, Ireland. 2. Department of Endocrinology, St. Vincent's University Hospital, Dublin, Ireland. 3. Clinical Chemistry, St. Vincent's University Hospital, Dublin, Ireland. 4. Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College, Dublin, Ireland; Department of Gastrosurgical Research & Education, Sahlgrenska Academy, University of Gothenburg, Sweden; Investigative Science, Imperial College London, United Kingdom. 5. Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College, Dublin, Ireland; Department of Gastrosurgical Research & Education, Sahlgrenska Academy, University of Gothenburg, Sweden. Electronic address: neil.docherty@ucd.ie.
Abstract
AIMS: Elevated plasma soluble tumour necrosis factor receptor 1 (TNFR1) predicts long-term progression of chronic kidney disease. We investigated the association between elevated TNFR1 and the presence of renal disease in patients with Type 2 diabetes mellitus registering a haemoglobin A1c (HbA1c) >48mmol/mol despite medical therapy. METHODS: Using sensitivity, specificity and regression analyses we interrogated the association between plasma TNFR1 and presence of chronic kidney disease as assessed by the presence of microalbuminuria and/or an estimated glomerular filtration rate of less than 60ml/min/1.73m2 (stages 3-5 chronic kidney disease). The association of TNFR1 with C-reactive protein and leptin-adiponectin ratio as plasma markers of systemic inflammation and adipose stress respectively was also investigated. RESULTS: Upper quartile TNFR1 is independently associated with elevated urinary albumin-creatinine ratios, reductions in eGFR and strongly predicts the presence of stages 3-5 chronic kidney disease in regression modelling. Elevated TNFR1 levels are associated with increased plasma C-reactive protein and augmented leptin-adiponectin ratio. CONCLUSIONS: Our study confirms plasma TNFR1 as a surrogate of renal structural and functional impairment in patients with type 2 diabetes mellitus. Association of TNFR1 with markers of systemic inflammation and adipose stress indicates that TNFR1 may be a biomarker of these processes as components of the pathogenesis of diabetic kidney disease.
AIMS: Elevated plasma soluble tumour necrosis factor receptor 1 (TNFR1) predicts long-term progression of chronic kidney disease. We investigated the association between elevated TNFR1 and the presence of renal disease in patients with Type 2 diabetes mellitus registering a haemoglobin A1c (HbA1c) >48mmol/mol despite medical therapy. METHODS: Using sensitivity, specificity and regression analyses we interrogated the association between plasma TNFR1 and presence of chronic kidney disease as assessed by the presence of microalbuminuria and/or an estimated glomerular filtration rate of less than 60ml/min/1.73m2 (stages 3-5 chronic kidney disease). The association of TNFR1 with C-reactive protein and leptin-adiponectin ratio as plasma markers of systemic inflammation and adipose stress respectively was also investigated. RESULTS: Upper quartile TNFR1 is independently associated with elevated urinary albumin-creatinine ratios, reductions in eGFR and strongly predicts the presence of stages 3-5 chronic kidney disease in regression modelling. Elevated TNFR1 levels are associated with increased plasma C-reactive protein and augmented leptin-adiponectin ratio. CONCLUSIONS: Our study confirms plasma TNFR1 as a surrogate of renal structural and functional impairment in patients with type 2 diabetes mellitus. Association of TNFR1 with markers of systemic inflammation and adipose stress indicates that TNFR1 may be a biomarker of these processes as components of the pathogenesis of diabetic kidney disease.
Authors: Jessica Gooding; Lei Cao; Faihaa Ahmed; Jean-Marie Mwiza; Mizpha Fernander; Courtney Whitaker; Zach Acuff; Susan McRitchie; Susan Sumner; Elimelda Moige Ongeri Journal: Am J Physiol Renal Physiol Date: 2019-08-14
Authors: Liliane Silvano Araújo; Bianca Gonçalves Silva Torquato; Crislaine Aparecida da Silva; Maria Luíza Gonçalves Dos Reis Monteiro; Ana Luisa Monteiro Dos Santos Martins; Marcos Vinícius da Silva; Marlene Antônia Dos Reis; Juliana Reis Machado Journal: BMC Nephrol Date: 2020-07-28 Impact factor: 2.388
Authors: Liliane Silvano Araújo; Marcos Vinícius da Silva; Crislaine Aparecida da Silva; Maria de Fátima Borges; Heloísa Marcelina da Cunha Palhares; Laura Penna Rocha; Rosana Rosa Miranda Corrêa; Virmondes Rodrigues Júnior; Marlene Antônia Dos Reis; Juliana Reis Machado Journal: PLoS One Date: 2020-03-04 Impact factor: 3.240
Authors: William P Martin; Colm Tuohy; Alison Doody; Sabrina Jackson; Ronan J Canavan; David Slattery; Patrick J Twomey; Malachi J McKenna; Carel W le Roux; Neil G Docherty Journal: Sci Rep Date: 2020-09-09 Impact factor: 4.379
Authors: Carla Harkin; Karl W Smith; C Logan MacKay; Tara Moore; Simon Brockbank; Mark Ruddock; Diego F Cobice Journal: Anal Bioanal Chem Date: 2022-07-26 Impact factor: 4.478